AnalystBook Research · Company Intelligence

ROPER TECHNOLOGIES INC

ROPNasdaq

Built from ROPER TECHNOLOGIES INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

ROPER TECHNOLOGIES INC: Revenue grew 12.3% to $7.902B from $7.039B. Net income declined 0.8% to $1.536B from $1.549B. Free cash flow grew 7.1% to $2.493B from $2.327B. Operating margin contracted 8 bps to 28.29%. ROPER TECHNOLOGIES INC's annual comparison also shows stock compensation grew faster than revenue; inventory grew faster than revenue.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue grew 12.3%OK
  • ProfitabilityNet income declined 0.8% to $1.536B from $1.549BWatch
  • Cash flowFree cash flow grew 7.1% to $2.493B from $2.327BOK
  • MarginsOperating margin contracted 8 bps to 28.29%Watch
  • AccountingNo overriding statistical warningNote
  • Insiders3 purchases and 4 salesOK

Business

Competition Generally, our products and solutions face significant competition, although in certain niche markets there are a limited number of competitors.

Where the revenue comes from

Fiscal 2025, as ROPER TECHNOLOGIES INC reports it. History and quarterly detail are in the app.

  • Application Software$4.5B
  • Technology Enabled Products$1.8B
  • Network Software$1.6B

Latest filings

  • 8-K · Company announcement2026-08-10
  • 10-Q · Quarterly report2026-07-31
  • 8-K · Company announcement2026-07-23
  • 8-K · Company announcement2026-05-19
  • 10-Q · Quarterly report2026-05-01
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about ROPER TECHNOLOGIES INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.